Neuronuclear Medicine and Imaging Consultant

The Organizations

SynterMed develops advanced medical imaging software, including NeuroQ, used to quantify and analyze brain PET scans for neurological research and clinical diagnosis.

Visit SynterMed Website

UCLA Health is a top-ranked academic medical center whose Nuclear Medicine and Molecular Imaging program is a recognized leader in brain PET research.

Visit UCLA Health Website

My Role & Research

At UCLA Health and SynterMed, I conduct quantitative neuroimaging research focused on brain PET analysis and Alzheimer's disease. My work includes quantifying FDG-PET scans with NeuroQ and validating the software across versions, processing settings, and diagnostic groups. I use Python to compare regional measurements, calculate agreement, run regressions, visualize results, and identify subject- and brain-region-level outliers.

I also curate and process tau and FDG-PET datasets to investigate regional relationships between tau accumulation and glucose metabolism. By comparing these patterns across normal aging, mild cognitive impairment, and Alzheimer's disease, I evaluate how tau and FDG-PET can contribute to the detection and characterization of Alzheimer's disease.

Note: research data shown has been anonymized.